Olsen M E, Hall J E, Montaini J P, Guyton A C
J Hypertens Suppl. 1984 Dec;2(3):S347-50.
The aim of this study was to determine the role of changes in renal artery pressure (RAP), renal haemodynamics, and tubular reabsorption in mediating the natriuretic and anti-natriuretic actions of angiotensin II (ANG II). In anaesthetized dogs, endogenous ANG II formation was blocked with SQ-14225 and ANG II was infused intravenously at rates of 5-1215 ng/kg/min while RAP was either servo-controlled at the normal level or permitted to increase. When RAP was servo-controlled to prevent a rise in RAP, ANG II infusion at all rates from 5-1215 ng/kg/min decreased urinary sodium excretion (INaV) and fractional sodium excretion (FENa), while increasing fractional reabsorption of lithium (FRLi), an index of proximal tubule fractional sodium reabsorption (FRDNa). When RAP was permitted to increase, ANG II infusion rates up to 45 ng/kg/min decreased UNaV, and FENam while increasing FRLi and FRDNa greater than However, at 135 ng/kg/min and above UNaV and FENE increased while FRLi and FRDNa decreased when RAP was allowed to rise, even though renal blood flow and filtration fraction were not substantially different from the values observed when RAP was servo-controlled. Filtered sodium load was slightly higher when RAP was permitted to increase during ANG II infusion, compared to the dogs in which RAP was servo-controlled, although the differences were not statistically significant. Thus, even very large doses of ANG II cause anti-natriuresis when RAP is prevented from increasing. The natriuretic effect of high doses of ANG II is caused by increased RAP which decreases fractional sodium reabsorption in proximal and distal tubules and causes slight increase in sodium delivery to the tubules.
本研究的目的是确定肾动脉压力(RAP)变化、肾血流动力学及肾小管重吸收在介导血管紧张素II(ANG II)的利钠和抗利钠作用中的作用。在麻醉犬中,用SQ - 14225阻断内源性ANG II生成,以5 - 1215 ng/kg/min的速率静脉输注ANG II,同时将RAP要么伺服控制在正常水平,要么任其升高。当RAP被伺服控制以防止其升高时,以5 - 1215 ng/kg/min的所有速率输注ANG II均会降低尿钠排泄(INaV)和钠排泄分数(FENa),同时增加锂的重吸收分数(FRLi),这是近端小管钠重吸收分数(FRDNa)的一个指标。当允许RAP升高时,高达45 ng/kg/min的ANG II输注速率会降低UNaV和FENam,同时增加FRLi和FRDNa,但高于此值;然而,当允许RAP升高时,在135 ng/kg/min及以上,UNaV和FENE增加,而FRLi和FRDNa降低,尽管肾血流量和滤过分数与RAP被伺服控制时观察到的值相比并无显著差异。与RAP被伺服控制的犬相比,在ANG II输注期间允许RAP升高时,滤过钠负荷略高,尽管差异无统计学意义。因此,当防止RAP升高时,即使是非常大剂量的ANG II也会引起抗利尿钠作用。高剂量ANG II的利钠作用是由RAP升高引起的,RAP升高会降低近端和远端小管的钠重吸收分数,并导致小管钠输送略有增加。